REVOLADE Novartis Pharmaceuticals Australia Pty Ltd

Revolade 75 mg film-coated tablets - revolade Revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia lasting 6 months or longer from revolade Revolade is a medicine that is used for the treatment of: • primary immune thrombocytopenia , a disease in which the patient's immune system destroys

revolade Revolade space ELTROMBOPAG Source, S100 HSD Public Body System, BLOOD AND BLOOD FORMING ORGANS > ANTIHEMORRHAGICS > VITAMIN K AND OTHER HEMOSTATICS Note